John Fetse

John Fetse is an Assistant Professor in the Department of Pharmaceutical Sciences at Binghamton University's School of Pharmacy and Pharmaceutical Sciences. He holds a PhD from the University of Missouri-Kansas City (UMKC), where his doctoral work focused on peptide-based immune checkpoint inhibitors for cancer immunotherapy. Previously, he served as an Assistant Professor at Larkin University College of Pharmacy in Miami.

Education:

• PhD in Pharmaceutical Sciences, University of Missouri-Kansas City (UMKC)
• M.Phil in Pharmaceutical Chemistry, Kwame Nkrumah University of Science and Technology (Ghana)
• B.Pharm, Kwame Nkrumah University of Science and Technology (Ghana)

Research Interests: His current research emphasizes peptide drug development, lipid nanoparticle systems for biologics delivery, and smart biomaterials for minimally invasive therapies. Key areas include cancer immunotherapy strategies targeting protein-protein interactions and design of ligands for targeted drug delivery.

Publications Trends: His most recent articles (2022–2025) focus on peptide-based immunotherapies, including tumor-activated checkpoint inhibitors and anti-PD-L1 peptides. He also explores lipid nanoparticle systems for siRNA delivery and novel xylopic acid derivatives with anxiolytic properties. Recent work combines nanomedicine with biomaterials for cancer treatment and viral inhibition.

Awards:

• American Association of Colleges of Pharmacy (AACP) New Investigator Award (2024)
• Leonard A. Levy Research Fund, Larkin University (2024)
• Larkin University Intramural Faculty Research Grant (2023)

Grants & Advising: His research has been supported by institutional grants. While no formal advisee list is provided, his lab focuses on training students in drug delivery and nanotechnology.

Labs & Teams: The Fetse Lab (https://www.fetse-lab.com/) specializes in developing innovative drug delivery systems and immunotherapeutics. Collaborations emphasize translational research in oncology and infectious diseases.